SRPT

Sarepta Therapeutics Inc.

Price

$22.15

return (12m)

p/e

27.57

p/bv

1.19

DIVIDEND YIELD

0.00%

SRPT price

Sarepta Therapeutics

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment SRPT

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

0.00%

3 months

0.00%

1 year

0.00%

2 years

0.00%

5 years

0.00%

10 years

0.00%

Fundamentals SRPT

Valuation

P/E

27.57

Sector 10.60

Industry 11.51

P/BV

1.19

Sector 1.66

Industry 2.49

P/Revenue (PSR)

0.82

Sector 1.00

Industry 1.58

EV/EBITDA

5.27

Sector 23.33

Industry 33.06

EV/EBIT

5.42

Sector 25.89

Industry 33.04

P/EBITDA

14.35

Sector 5.33

Industry 6.93

P/EBIT

22.47

Sector 6.99

Industry 8.08

P/Total Assets

0.56

Sector 0.81

Industry 1.25

P/Net Current Assets

2.82

Sector -6.03

Industry -2.43

P/Working Capital

0.99

Sector -3.78

Industry 2.55

EPS

0.62

Sector 0.78

Industry 0.64

BVPS

14.33

Sector 10.32

Industry 7.94

Efficiency

Gross Margin

62.88%

Sector 39.03%

Industry 43.28%

EBITDA Margin

51.38%

Sector 8.03%

Industry 6.47%

EBIT Margin

49.93%

Sector 3.44%

Industry 3.57%

Operating Margin

0.05%

Sector 5.63%

Industry 6.47%

Net Profit Margins

2.98%

Sector 1.81%

Industry 3.16%

Asset Turnover

0.23

Sector 0.21

Industry 0.18

Profitability

ROE

4.32%

Sector 3.89%

Industry 6.71%

ROA

2.05%

Sector 0.96%

Industry 0.65%

ROIC

65.13%

Sector -9.37%

Industry -30.05%

Dividends

Dividend yield

0.00%

Sector 0.38%

Industry 0.21%

Payout

0.00%

Sector 9.79%

Industry 6.95%

Debt

Current Ratio

4.63

Sector 1.12

Industry 1.68

Net Debt / EBITDA

0.49

Sector 1.61

Industry 3.13

Net Debt / EBIT

0.51

Sector 1.59

Industry 3.34

Net Debt / Equity

0.12

Sector -0.11

Industry -0.01

Gross Debt / Equity

0.56

Sector 0.23

Industry 0.05

Equity/Assets

0.47

Sector 0.31

Industry 0.41

Liabilities/Assets

0.53

Sector 0.60

Industry 0.52

Growth

5Y Revenue CAGR

25.49%

Sector -

Industry -

5Y Earnings CAGR

0.00%

Sector -

Industry -

FAIR VALUE OF Sarepta Therapeutics ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Value

The Fair Value formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffett’s mentor.

Current price

$22.15

Fair Value

$14.14

Upside Return potential.

-36.17%

See Graham's ranking

Because it considers equity value in its calculation, this formula may not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

Fundamentals SRPT

DRAG THE FRAME TO SEE MORE DATA

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
SRPT Sarepta Therapeutics Inc.	$22.15	-56.59%	0.00%	27.57	1.19	4.32%	2.98%
HCSG Healthcare Services Group Inc.	$19.03	94.78%	0.00%	25.90	3.42	13.21%	3.66%
V Visa Inc.	$311.40	-5.90%	0.73%	29.10	18.14	62.35%	51.68%
MCO Moody's Corporation	$438.22	3.09%	0.77%	36.08	28.64	79.38%	31.69%
CECE CECO Environmental Corp.	$0.00	-	0.00%	41.22	2.12	5.15%	6.94%
QNST QuinStreet Inc.	$12.17	-19.99%	0.00%	14.77	3.11	21.05%	5.53%
BKNG Booking Holdings Inc.	$181.12	-0.52%	0.89%	23.11	-16.30	-70.54%	22.23%
PAE PAE Incorporated	$0.00	-	0.00%	14.74	8.39	56.94%	1.31%
PAEWW PAE Incorporated	$0.00	-	0.00%	3.34	1.37	40.94%	1.57%
TIF Tiffany & Co.	$0.00	-	0.00%	34.21	5.03	14.71%	10.91%
HQI HireQuest Inc.	$10.38	1.48%	1.94%	26.52	2.57	9.68%	21.96%
HSII Heidrick & Struggles International Inc.	$0.00	-100.00%	1.02%	33.45	2.43	7.28%	3.04%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

SRPT Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Sarepta Therapeutics

Sarepta Therapeutics Inc.

Average Investor10 user rating

4.0 (0 people)

States of America

46 years

Founded: 1980

1997

Time since IPO - 29 years

866

Employees

Sarepta Therapeutics Inc. (States of America) is listed on the Nasdaq and has a market capitalization of $1.79 billion, with shareholders equity totaling $1.51 billion.

The company employs approximately 866 people and operates in the Services sector, within the Serviços Comerciais industry.

Over the past 12 months, Sarepta Therapeutics Inc. reported $2.18 billion in revenue, generating net income of $65.05 million.

Key financial metrics include a P/E ratio of 27.57, a price-to-book (P/B) ratio of 1.19, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker SRPT.

Market cap

$1.79 billion

Net worth

$1.51 billion

$1,505,100,000.00

Assets

$3.18 billion

$3,178,930,000.00

Total Shares Outstanding

105.00 million

105,000,000

Average Daily Trading Volume

$3.53 million

$3,533,592.00

Sector

Services

Industry

Serviços Comerciais

SRPT

SRPT revenue and profits

Financial Results SRPT

DRAG THE FRAME TO SEE MORE DATA

SRPT cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

AMZN - Amazon

$1,000.00 -0,00% (12M)

P/E

29.33

0.00%

ROE

20.55%

P/BV

6.03

WMT - Walmart

$125.05 29,70% (12M)

P/E

40.00

0.85%

ROE

22.52%

P/BV

9.01

COST - Costco Wholesale

$974.80 4,80% (12M)

P/E

47.10

0.57%

ROE

26.38%

P/BV

12.42

KR - Kroger

$67.19 --1,08% (12M)

P/E

34.66

2.38%

ROE

16.12%

P/BV

5.59

JD - JD.com

$31.25 --2,71% (12M)

P/E

17.85

3.85%

ROE

4.80%

P/BV

0.86

HD - Home Depot

$342.69 --7,44% (12M)

P/E

24.42

2.69%

ROE

100.99%

P/BV

24.66

WBA - Walgreens Boots Alliance

$- -0,00% (12M)

P/E

-1.76

4.17%

ROE

-80.35%

P/BV

1.42

BABA - Alibaba

$131.35 7,53% (12M)

P/E

18.36

0.91%

ROE

8.96%

P/BV

1.64